Endocrine cardiomyopathy in cushing syndrome: Response to cyclic GMP PDE5 inhibitOrs

Registry ID

EUCTR2015-004497-15

Source registry

EUCTR

Status

Ongoing

Phase

PHASE2

Sponsor

UMBERTO I - POLICLINICO DI ROMA

Start date

2016-09-01

Last update

2026-08-16

Conditions

• Cushing’s Syndrome

Summary

The Primary Objective is to evaluate the effects of PDE5Ai on LV torsion angle as kinetic parameter of cardiac remodeling, measured at cine cardiac magnetic resonance (CMR) with tagging technique and contrast-enhanced in patients with CS cardiomyopathy

Locations

• , , Italy

View on source registry